Clinical ResearchZotarolimus- and Paclitaxel-Eluting Stents in an All-Comer Population in China: The RESOLUTE China Randomized Controlled Trial
Under an Elsevier user license
open archive
Key Words
all-comer population
China
drug-eluting stent
paclitaxel-eluting stent
randomized controlled trial
Resolute zotarolimus-eluting stent
Abbreviations and Acronyms
%DS
percent diameter stenosis
CI
confidence interval
DES
drug-eluting stent(s)
LLL
late lumen loss
MI
myocardial infarction
MLD
minimal lumen diameter
PES
paclitaxel-eluting stent(s)
R-ZES
Resolute zotarolimus-eluting stent(s)
TLF
target lesion failure
TLR
target lesion revascularization
TVF
target vessel failure
TVMI
target vessel myocardial infarction
TVR
target vessel revascularization
Cited by (0)
This study was funded by Medtronic. Dr. Xu has received financial support from Abbott Vascular, Medtronic, and MicroPort. Drs. Yang, Yuan, Du, and LU have received financial support from Medtronic. Dr. Wong is a member of the Speakers' Bureau and advisory board of Medtronic. Dr. Généreux has reported that he has no relationships relevant to the contents of this paper to disclose.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.